ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Rosiglitazone on Regression of Atherosclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00166803
Recruitment Status : Suspended (no fund)
First Posted : September 14, 2005
Last Update Posted : January 5, 2009
Sponsor:
Collaborator:
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : November 2008
  Study Completion Date : No date given